Literature DB >> 21904146

Risk-adjusted colon and rectal cancer incidence rates in the United States.

Ray M Merrill1, Allison E Anderson.   

Abstract

BACKGROUND: Population-based cancer incidence rates that adjust for multiple cancer primaries and for prevalent cases of the disease provide a better approximation of risk.
DESIGN: This study is based on a retrospective cohort. SETTING/PATIENTS: Included in the study were 9 original Surveillance, Epidemiology and End Results registries focusing on white and black males and females from 2000 through 2007. MAIN OUTCOME MEASURE: The main outcome measured was malignant colorectal cancer.
RESULTS: Conventional colorectal cancer incidence rates overestimate population risk by 3.6% for white males, 4.0% for black males, 3.4% for white females, and 3.3% for black females. The level of overestimation bias remained similar across the age span for white and black males. However, for white females, rates were overestimated by 2.1% for ages 30 to 39 and increased to 3.8% for ages 80 years and older. Corresponding values for black females were 1.5% and 3.8%. The trends in conventional rates were generally similar to the trends in risk-adjusted incidence rates, increasing or stable before age 50, but decreasing thereafter. The number of colorectal cancer cases in the United States is estimated from conventional incidence rates. In 2007, the number of colorectal cases was 59,599 for white males, 7,670 for black males, 58,972 for white females, and 8,786 for black females. The number of colorectal cancer cases based on prevalence-corrected incidence rates increased by 2.2% for white males, 1.5% for black males, 2.1% for white females, and 1.5% for black females.
CONCLUSION: Colorectal cancer incidence rates that include second and later colorectal cancer primaries and adjust for prevalence better reflect cancer burden, whereas colorectal cancer incidence rates that only include the first diagnosed case and adjust for prevalence better reflect cancer risk.

Entities:  

Mesh:

Year:  2011        PMID: 21904146     DOI: 10.1097/DCR.0b013e3182242bd3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  11 in total

1.  Stem cell gene Girdin: a potential early liver metastasis predictor of colorectal cancer.

Authors:  Chen Liu; Hongpeng Xue; Yixia Lu; Baorong Chi
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

Review 2.  Colorectal cancer in the young, many questions, few answers.

Authors:  Kemal I Deen; Hiroshi Silva; Raeed Deen; Pramodh C Chandrasinghe
Journal:  World J Gastrointest Oncol       Date:  2016-06-15

Review 3.  Advanced colorectal polyp detection techniques.

Authors:  Bashar J Qumseya; Michael B Wallace
Journal:  Curr Gastroenterol Rep       Date:  2012-10

4.  Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jolanda de Boer; Theodore R Levin; Chyke Doubeni; Bruce H Fireman; Charles P Quesenberry
Journal:  Clin Gastroenterol Hepatol       Date:  2012-09-14       Impact factor: 11.382

5.  The effect of polyp location and patient gender on the presence of dysplasia in colonic polyps.

Authors:  Bashar J Qumseya; Susan Coe; Michael B Wallace
Journal:  Clin Transl Gastroenterol       Date:  2012-07-26       Impact factor: 4.488

Review 6.  New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds.

Authors:  Saúl Redondo-Blanco; Javier Fernández; Ignacio Gutiérrez-Del-Río; Claudio J Villar; Felipe Lombó
Journal:  Front Pharmacol       Date:  2017-03-14       Impact factor: 5.810

7.  Functional Anthocyanin-Rich Sausages Diminish Colorectal Cancer in an Animal Model and Reduce Pro-Inflammatory Bacteria in the Intestinal Microbiota.

Authors:  Javier Fernández; Lorena García; Joaquín Monte; Claudio J Villar; Felipe Lombó
Journal:  Genes (Basel)       Date:  2018-03-01       Impact factor: 4.141

8.  A Galacto-Oligosaccharides Preparation Derived From Lactulose Protects Against Colorectal Cancer Development in an Animal Model.

Authors:  Javier Fernández; F J Moreno; Agustín Olano; Alfonso Clemente; Claudio J Villar; Felipe Lombó
Journal:  Front Microbiol       Date:  2018-08-31       Impact factor: 5.640

9.  Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α.

Authors:  Alaa A A Aljabali; Hamid A Bakshi; Faruk L Hakkim; Yusuf A Haggag; Khalid M Al-Batanyeh; Mazhar S Al Zoubi; Bahaa Al-Trad; Mohamed M Nasef; Saurabh Satija; Meenu Mehta; Kavita Pabreja; Vijay Mishra; Mohammed Khan; Salem Abobaker; Ibrahim M Azzouz; Harish Dureja; Ritesh M Pabari; Ashref Ali K Dardouri; Prashant Kesharwani; Gaurav Gupta; Shakti Dhar Shukla; Parteek Prasher; Nitin B Charbe; Poonam Negi; Deepak N Kapoor; Dinesh Kumar Chellappan; Mateus Webba da Silva; Paul Thompson; Kamal Dua; Paul McCarron; Murtaza M Tambuwala
Journal:  Cancers (Basel)       Date:  2020-01-01       Impact factor: 6.639

10.  Clinicopathological Features and Survival Outcomes of Colorectal Cancer in Young Versus Elderly: A Population-Based Cohort Study of SEER 9 Registries Data (1988-2011).

Authors:  Rui Wang; Mo-Jin Wang; Jie Ping
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.